Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19

doi:10.3748/wjg.v27.i33.5502

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7839)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

517

WORD

216

HTML

4530

Figures (1-3)

300

Tables (1-2)

302

Sum=5865

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

291

Download

265

Sum=556

Publishing Process of This Article

Item

Count

Browse

547

Download

871

Sum=1418

Sep 7, 2021 (publication date) through Jan 30, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Sep 7, 2021; 27(33): 5502-5519
Published online Sep 7, 2021. doi: 10.3748/wjg.v27.i33.5502

Full Size Figure Download Figure

Figure 1 Total coronavirus disease 2019 cases and nonalcoholic fatty liver disease prevalence. United States of America 25439570, India 10689527, Brazil 8933356, Russia 3716228, United Kingdom 3700268, France 3138498, Spain 2629817, Italy 2485956, Turkey 2442350, Germany 2164043.

Citation: Campos-Murguía A, Román-Calleja BM, González-Regueiro JA, Hurtado-Díaz-de-León I, Solís-Ortega AA, Flores-García NC, García-Juárez I, Ruiz-Margáin A, Macías-Rodríguez RU. Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19. World J Gastroenterol 2021; 27(33): 5502-5519
URL: https://www.wjgnet.com/1007-9327/full/v27/i33/5502.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i33.5502